Previous 10 | Next 10 |
home / stock / lzagy / lzagy news
2024-02-11 12:00:03 ET More on Eli Lilly, Novo Nordisk, etc. Will Eli Lilly and Company Become A Trillion-Dollar Baby? Eli Lilly and Company: Even 'Miracle Drugs' Can't Keep Stock Rising (Downgrade) Eli Lilly and Co (LLY) Q4 2023 Earnings Conference Call Transcript ...
2024-01-27 10:40:00 ET Summary Lonza Group aims to increase revenue by double digits by 2028 through aggressive expansion in the CDMO space. Lonza expects to increase its EBITDA margin to 32%-34% by 2028 and maintain a low debt ratio. The company plans to generate 25% of its r...
2024-01-26 13:14:05 ET Lonza Group AG (LZAGY) Q4 2023 Earnings Conference Call January 26, 2024, 08:00 AM ET Company Participants Albert Baehny - CEO ad Interim and Chairman of the Board of Directors Philippe Deecke - CFO Conference Call Participants Rich...
2024-01-26 11:52:39 ET More on Lonza Lonza not planning to manufacture GLP-1 drugs: report Historical earnings data for Lonza Group Dividend scorecard for Lonza Group Financial information for Lonza Group Seeking Alpha’s Quant Rating on Lonza G...
2024-01-26 09:43:23 ET More on Lonza Group AG Lonza not planning to manufacture GLP-1 drugs: report Seeking Alpha’s Quant Rating on Lonza Group AG Historical earnings data for Lonza Group AG Dividend scorecard for Lonza Group AG Financial infor...
2024-01-25 10:23:28 ET Major earnings expected before the bell on Friday include: American Express ( AXP ) Booz Allen Hamilton Holding ( BAH ) Colgate-Palmolive ( CL ) Norfolk Southern ( NSC ) Oxford Lane Capital ( OXLC ) Read the full artic...
FFW Corp. (FFWC) is expected to report for Q2 2024 ResMed Inc. (RMD) is expected to report $1.81 for Q2 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2023-12-31 ChoiceOne Financial Services Inc. (COFS) is expected to report $0.64 for Q4 2023 First ...
Lonza Group AG ADR (LZAGY) is expected to report for Q4 2023
2023-11-29 17:57:54 ET Summary Ajinomoto is diversifying its revenue segments, particularly in the biopharma and semiconductor industries, for organic growth opportunities. The company has a leading market position, high R&D investment, and above-peer margins in the consumer s...
2023-11-17 16:16:14 ET More on Lonza Group AG Lonza: The Day Has Come, And We Lower Our Expectation Lonza Group: Downside Scenario Already Priced In Historical earnings data for Lonza Group AG Dividend scorecard for Lonza Group AG Financial informatio...
News, Short Squeeze, Breakout and More Instantly...
Lonza Group AG ADR Company Name:
LZAGY Stock Symbol:
OTCMKTS Market:
NeuroSense Announces First Quarter 2024 Business Update PR Newswire CAMBRIDGE, Mass. , May 2, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today ...
FFW Corp. (FFWC) is expected to report for Q2 2024 ResMed Inc. (RMD) is expected to report $1.81 for Q2 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2023-12-31 ChoiceOne Financial Services Inc. (COFS) is expected to report $0.64 for Q4 2023 First ...
Lonza Group AG ADR (LZAGY) is expected to report for Q4 2023